指南与共识妇科

NCCN指南依从性是卵巢癌黑人与白人患者生存差异的主要决定因素

Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
指南 / 共识 · Gynecol Oncol · 2020-11-15

该大型队列研究纳入2004至2014年诊断的120,712例卵巢癌患者,评估NCCN治疗指南依从性等因素对种族生存差异的贡献。黑人患者指南依从性低于白人(60.8% vs. 70.4%,P<0.001),五年死亡风险更高(校正HR 1.22,95%CI 1.19-1.25)。不依从指南是生存差异的最主要贡献因素,解释36.4%的差异,与就医可及性和合并症合计解释59.1%。

要点

  • 黑人卵巢癌患者NCCN指南依从性显著低于白人(60.8% vs. 70.4%)。
  • 不依从指南解释种族五年生存差异的36.4%,为最大贡献因素。
  • 就医可及性和合并症分别解释22.7%和18.2%的生存差异。

核心结论

  • NCCN治疗指南依从性是卵巢癌黑人与白人患者生存差异的最重要贡献因素。
  • 呼吁采取措施促进公平获得指南依从性治疗以改善黑人女性卵巢癌生存。

研究设计与样本

  • 基于美国国家癌症数据库的大型队列研究,纳入2004至2014年诊断的卵巢癌患者,随访至2017年。
  • 共120,712例 eligible 患者,其中白人110,032例(91.1%),黑人10,680例(8.9%)。
  • 采用多因素Cox回归评估五年总生存,并通过个体和序贯调整估计各预后因素的贡献比例。

主要发现

  • 黑人患者NCCN指南依从性为60.8%,白人患者为70.4%(P<0.001)。
  • 黑人患者较白人患者五年死亡风险更高,年龄和肿瘤特征校正后HR为1.22(95%CI 1.19-1.25)。
  • 不依从NCCN指南解释种族五年总生存差异的36.4%,就医可及性解释22.7%,合并症解释18.2%。
  • 上述因素合计解释59.1%的种族生存差异。
  • 黑人患者中不依从指南的风险因素包括保险状态、治疗机构类型、教育程度、年龄和合并症。

关键数值与推荐

  • NCCN指南依从性:黑人60.8% vs. 白人70.4%(P<0.001)。
  • 五年死亡风险校正HR:1.22(95%CI 1.19-1.25),黑人 vs. 白人。
  • 各因素对种族生存差异的贡献:不依从指南36.4%,就医可及性22.7%,合并症18.2%,合计59.1%。

临床怎么用

  • 临床应关注卵巢癌患者对NCCN指南治疗的依从性,尤其针对黑人患者。
  • 识别不依从高风险人群(如保险状态、治疗机构类型、教育程度、年龄、合并症)并针对性干预。
  • 推动公平获得指南依从性治疗以缩小生存差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether non-adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines and other factors related to treatment access contribute to racial disparities in ovarian cancer survival. METHODS: This large cohort study included patients from the National Cancer Database who were diagnosed with ovarian cancer between 2004 and 2014, with follow-up data up to 2017. The multivariable Cox regression was used to assess the effect of study variables on five-year overall survival. The proportion contributions of prognostic factors to the survival disparities were estimated using individual and sequential adjustment of these factors based on the Cox proportional hazards models. RESULTS: Of the 120,712 patients eligible for this study, 110,032 (91.1%) were whites and 10,680 (8.9%) were blacks. Black patients, compared with their white counterparts, had a lower adherence to NCCN guidelines (60.8% vs. 70.4%, respectively, P < 0.001), and a higher five-year mortality after cancer diagnosis (age- and tumor characteristics- adjusted hazard ratio: 1.22, 95% confidence interval: 1.19-1.25). Non-adherence to NCCN treatment guidelines was the most significant contributor to racial disparity in ovarian cancer survival, followed by access to care and comorbidity, each explaining 36.4%, 22.7%, and 18.2% of the racial differences in five-year overall survival, respectively. These factors combined explain 59.1% of racial survival disparities. Risk factors identified for non-adherence to treatment guidelines among blacks include insurance status, treatment facility type, educational attainment, age, and comorbidity. CONCLUSIONS: Adherence status to NCCN treatment guidelines is the most important contributor to the survival disparities between black and white patients with ovarian cancer. Our findings call for measures to promote equitable access to guideline-adherence care to improve the survival of black women with ovarian cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Chen F, Bailey CE, Alvarez RD, et al. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer. Gynecol Oncol. 2020. PMID: 33208254. doi:10.1016/j.ygyno.2020.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。